Literature DB >> 24239252

Malaria vaccine technology roadmap.

Vasee S Moorthy1, Robert D Newman, Jean-Marie Okwo-Bele.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24239252     DOI： 10.1016/S0140-6736(13)62238-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  50 in total

1.  Synergistic and antagonistic interactions between bednets and vaccines in the control of malaria.

Authors:  Yael Artzy-Randrup; Andrew P Dobson; Mercedes Pascual
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-20       Impact factor: 11.205

2.  Immunization with full-length Plasmodium falciparum merozoite surface protein 1 is safe and elicits functional cytophilic antibodies in a randomized first-in-human trial.

Authors:  Antje Blank; Kristin Fürle; Anja Jäschke; Michael Lanzer; Walter E Haefeli; Hermann Bujard; Gerd Mikus; Monika Lehmann; Johannes Hüsing; Kirsten Heiss; Thomas Giese; Darrick Carter; Ernst Böhnlein
Journal:  NPJ Vaccines       Date:  2020-01-31       Impact factor: 7.344

Review 3.  New insight-guided approaches to detect, cure, prevent and eliminate malaria.

Authors:  Sushil Kumar; Renu Kumari; Richa Pandey
Journal:  Protoplasma       Date:  2014-10-17       Impact factor: 3.356

4.  Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions.

Authors:  Ruth O Payne; Sarah E Silk; Sean C Elias; Kazutoyo Miura; Ababacar Diouf; Francis Galaway; Hans de Graaf; Nathan J Brendish; Ian D Poulton; Oliver J Griffiths; Nick J Edwards; Jing Jin; Geneviève M Labbé; Daniel Gw Alanine; Loredana Siani; Stefania Di Marco; Rachel Roberts; Nicky Green; Eleanor Berrie; Andrew S Ishizuka; Carolyn M Nielsen; Martino Bardelli; Frederica D Partey; Michael F Ofori; Lea Barfod; Juliana Wambua; Linda M Murungi; Faith H Osier; Sumi Biswas; James S McCarthy; Angela M Minassian; Rebecca Ashfield; Nicola K Viebig; Fay L Nugent; Alexander D Douglas; Johan Vekemans; Gavin J Wright; Saul N Faust; Adrian Vs Hill; Carole A Long; Alison M Lawrie; Simon J Draper
Journal:  JCI Insight       Date:  2017-11-02

5.  Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial.

Authors:  Mehreen S Datoo; Magloire H Natama; Athanase Somé; Ousmane Traoré; Toussaint Rouamba; Duncan Bellamy; Prisca Yameogo; Daniel Valia; Moubarak Tegneri; Florence Ouedraogo; Rachidatou Soma; Seydou Sawadogo; Faizatou Sorgho; Karim Derra; Eli Rouamba; Benedict Orindi; Fernando Ramos Lopez; Amy Flaxman; Federica Cappuccini; Reshma Kailath; Sean Elias; Ekta Mukhopadhyay; Andres Noe; Matthew Cairns; Alison Lawrie; Rachel Roberts; Innocent Valéa; Hermann Sorgho; Nicola Williams; Gregory Glenn; Louis Fries; Jenny Reimer; Katie J Ewer; Umesh Shaligram; Adrian V S Hill; Halidou Tinto
Journal:  Lancet       Date:  2021-05-05       Impact factor: 202.731

6.  MALVAC 2012 scientific forum: accelerating development of second-generation malaria vaccines.

Authors:  Kirsten S Vannice; Graham V Brown; Bartholomew D Akanmori; Vasee S Moorthy
Journal:  Malar J       Date:  2012-11-09       Impact factor: 2.979

7.  Demonstration of the Blood-Stage Plasmodium falciparum Controlled Human Malaria Infection Model to Assess Efficacy of the P. falciparum Apical Membrane Antigen 1 Vaccine, FMP2.1/AS01.

Authors:  Ruth O Payne; Kathryn H Milne; Sean C Elias; Nick J Edwards; Alexander D Douglas; Rebecca E Brown; Sarah E Silk; Sumi Biswas; Kazutoyo Miura; Rachel Roberts; Thomas W Rampling; Navin Venkatraman; Susanne H Hodgson; Geneviève M Labbé; Fenella D Halstead; Ian D Poulton; Fay L Nugent; Hans de Graaf; Priya Sukhtankar; Nicola C Williams; Christian F Ockenhouse; April K Kathcart; Aziz N Qabar; Norman C Waters; Lorraine A Soisson; Ashley J Birkett; Graham S Cooke; Saul N Faust; Colleen Woods; Karen Ivinson; James S McCarthy; Carter L Diggs; Johan Vekemans; Carole A Long; Adrian V S Hill; Alison M Lawrie; Sheetij Dutta; Simon J Draper
Journal:  J Infect Dis       Date:  2016-02-04       Impact factor: 5.226

Review 8.  Vectored Immunotherapeutics for Infectious Diseases: Can rAAVs Be The Game Changers for Fighting Transmissible Pathogens?

Authors:  Wei Zhan; Manish Muhuri; Phillip W L Tai; Guangping Gao
Journal:  Front Immunol       Date:  2021-05-11       Impact factor: 7.561

9.  Qualification of standard membrane-feeding assay with Plasmodium falciparum malaria and potential improvements for future assays.

Authors:  Kazutoyo Miura; Bingbing Deng; Gregory Tullo; Ababacar Diouf; Samuel E Moretz; Emily Locke; Merribeth Morin; Michael P Fay; Carole A Long
Journal:  PLoS One       Date:  2013-03-06       Impact factor: 3.240

10.  Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination.

Authors:  Angela M Minassian; Sarah E Silk; Jordan R Barrett; Carolyn M Nielsen; Kazutoyo Miura; Ababacar Diouf; Carolin Loos; Jonathan K Fallon; Ashlin R Michell; Michael T White; Nick J Edwards; Ian D Poulton; Celia H Mitton; Ruth O Payne; Michael Marks; Hector Maxwell-Scott; Antonio Querol-Rubiera; Karen Bisnauthsing; Rahul Batra; Tatiana Ogrina; Nathan J Brendish; Yrene Themistocleous; Thomas A Rawlinson; Katherine J Ellis; Doris Quinkert; Megan Baker; Raquel Lopez Ramon; Fernando Ramos Lopez; Lea Barfod; Pedro M Folegatti; Daniel Silman; Mehreen Datoo; Iona J Taylor; Jing Jin; David Pulido; Alexander D Douglas; Willem A de Jongh; Robert Smith; Eleanor Berrie; Amy R Noe; Carter L Diggs; Lorraine A Soisson; Rebecca Ashfield; Saul N Faust; Anna L Goodman; Alison M Lawrie; Fay L Nugent; Galit Alter; Carole A Long; Simon J Draper
Journal:  Med (N Y)       Date:  2021-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.